Justyna Filant

AstraZeneca (Poland) — Poland

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index2.5kcitations58works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Extracellular vesicles in disease(21), MicroRNA in disease regulation(11), Reproductive System and Pregnancy(11), RNA Interference and Gene Delivery(7), RNA modifications and cancer(7)

Publications58 total

TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors.
Journal of Clinical Oncology·2023· 20 cited
Abstract CT058: TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors
Cancer Research·2023· 1 cited
Supplementary Figures 1 - 2 from Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
2023Open Access
Data from Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer
2023Open Access
Data from Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
2023Open Access
Data from Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
2023Open Access
Supplementary Figures 1 - 2 from Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
2023Open Access
Supplementary figures S1-S3 from Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer
2023Open Access
Supplementary figures S1-S3 from Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer
2023Open Access
Data from Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer
2023Open Access
Data from Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
2023Open Access
Supplementary Methods from Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
2023Open Access
Supplementary Methods from Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
2023Open Access
Supplementary Figures and Tables from Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
2023Open Access
Data from Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
2023Open Access
Supplementary Figures and Tables from Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
2023Open Access
Supplementary Figure Legends from Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
2023Open Access
Supplementary Figure Legends from Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
2023Open Access
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression
UNC Libraries·2020Open Access
Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression
RePEc: Research Papers in Economics·2020
page 1 of 3Next →

Frequent Co-authors

Anil K. Sood(20), Gabriel Lopez‐Berestein(19), Cristina Ivan(15), Anil K. Sood(14), George A. Călin(13), Rajesha Rupaimoole(12), Sherry Y. Wu(12), Kshipra M. Gharpure(12), Archana S. Nagaraja(12), Sunila Pradeep(11), Chad V. Pecot(11), Thomas E. Spencer(11), Cristian Rodriguez-Aguayo(11), Heather J. Dalton(10), Behrouz Zand(9), Mohammed H. Rashed(9), Xinna Zhang(9), Andreia Silva(9), Srimeenakshi Srinivasan(8), Louise C. Laurent(8)